Recent prosecutions have heightened the risk for both market share discounts and discounts in lieu of service fees.
Products include oral suspension for gout and tablets that prevent low carnitine levels in the blood.
Whether practicing pharmacy in the ambulatory or inpatient setting, professionals devote a substantial amount of energy and time to appropriate dosing of medications for renal impairment.
Melatonin, an endogenous, or natural, hormone mainly produced by the pineal gland in the brain, regulates several body processes, including circadian rhythm and sleep patterns.
Data from 2 studies evaluating guselkumab (Tremfya, Janssen) in active psoriatic arthritis were presented at the American College of Rheumatology and Association of Rheumatology Professionals 2019 Annual Meeting.
Adherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Cell-based vaccines have many potential advantages, one of which includes longer stability and more rapid manufacturing, as cellbased vaccines can be frozen and used at a later date, with dependable cell lines to ensure consistent supply.
The FDA has just approved Shire's Cuvitru for primary immunodeficiency in patients 2 years and older.
A pharmacist offers her observations on patient-centered care.
The FDA recently approved an Investigational New Drug application submitted by Valneva SE.
As we head into flu season, count on Pharmacy Times® to continue to report on the latest developments on COVID-19.
Researchers from Australia set out to determine health consumers' information needs and concerns related to childhood vaccination.
The National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.
A team of researchers from Columbia University, New York City compared the incidence of chlamydia infection in adolescent LARC users to non-LARC users.
Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
A common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.
In uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.
Pharmacists must understand the potential value of biosimilars as a competitive generation of more cost efficient drugs hit the market.
Leukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.
Pharmacists can learn about current management of allergic rhinitis, including allergen avoidance, immunotherapy, and pharmacotherapy.
Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.
Health care compliance analytics can be used to roll out institution-wide training and education programs to deter sloppy or nefarious behavior related to controlled substances.